WCM
ORTX

Weld Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Weld Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,648
Closed -$114K – 603
2020
Q4 		$114K Buy
2,648
+556
+27% +$24.9K 0.04% 441
2020
Q3 		$86K Buy
2,092
+282
+16% +$14.6K 0.03% 452
2020
Q2 		$109K Buy
1,810
+437
+32% +$40K 0.04% 435
2020
Q1 		$103K Sell
1,373
-1,973
-59% -$227K 0.05% 371
2019
Q4 		$460K Buy
+3,346
New +$407K 0.09% 376

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Weld Capital Management's ORTX Position: Q1 2021 in Review

Weld Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2021, closing a stake of 2,648 shares — an estimated $114K sold.

Weld Capital Management first reported a position in ORTX in Q4 2019 and held it in 5 quarters. The position peaked at $460K in Q4 2019. 83 funds tracked by Wall St. Rank hold ORTX as of Q1 2021.

  • Weld Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 2,648 Orchard Therapeutics plc American Depositary Shares shares in Q1 2021, an estimated $114K.
  • Weld Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 5 quarters.
  • Weld Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $460K in Q4 2019.
  • 83 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.